Who has invested in Melt Pharmaceuticals?

Harrow, Inc. are named among the investors backing Melt Pharmaceuticals.

Melt Pharmaceuticals Funding: $24M Raised, Series B (2024)

Melt Pharmaceuticals funding overview

Melt Pharmaceuticals is based in Nashville, TN. Melt Pharmaceuticals has raised $24M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for Melt Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include Harrow, Inc..

Melt Pharmaceuticals at a glance

Total raised: $24M
Latest round: Series B
Latest round date: April 2024
Headquarters: Nashville, TN
Notable investors: Harrow, Inc.

Frequently asked about Melt Pharmaceuticals funding

How much has Melt Pharmaceuticals raised?: Melt Pharmaceuticals has raised $24M in total disclosed funding across the rounds on record.
Who has invested in Melt Pharmaceuticals?: Harrow, Inc. are named among the investors backing Melt Pharmaceuticals.
What was the latest Melt Pharmaceuticals funding round?: The most recent disclosed round is a Series B, announced in April 2024.
Where is Melt Pharmaceuticals based?: Melt Pharmaceuticals is based in Nashville, TN.
When did Melt Pharmaceuticals last raise?: The last disclosed Melt Pharmaceuticals round closed in April 2024 at Series B.

Round data for Melt Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Nashville and backer lists below.

Melt Pharmaceuticals Funding: $24M Raised, Series B (2024)

Melt Pharmaceuticals funding overview

Melt Pharmaceuticals at a glance

Frequently asked about Melt Pharmaceuticals funding

Companies related to Melt Pharmaceuticals (18)

Browse related funding lists (3)